{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:47:45Z","timestamp":1792079265863,"version":"4.4.0"},"reference-count":51,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shanghai Science and Technology Commission of Shanghai Municipality","award":["19DZ2280300"],"award-info":[{"award-number":["19DZ2280300"]}]},{"name":"Shanghai Science and Technology Commission of Shanghai Municipality","award":["ZJ2021-ZD-007"],"award-info":[{"award-number":["ZJ2021-ZD-007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072085"],"award-info":[{"award-number":["82072085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2020YFA0909003"],"award-info":[{"award-number":["2020YFA0909003"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2022,11,12]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Myeloid\u2010derived suppressor cells (MDSCs) can potently inhibit T-cell activity, promote growth and metastasis of tumor and contribute to resistance to immunotherapy. Targeting MDSCs to alleviate their protumor functions and immunosuppressive activities is intimately associated with cancer immunotherapy. Natural killer (NK) cells can engage in crosstalk with multiple myeloid cells to alter adaptive immune responses, triggering T-cell immunity. However, whether the NK-cell-MDSC interaction can modulate the T-cell immune response requires further study. Cryo-thermal therapy could induce the maturation of MDSCs by creating an acute inflammatory environment to elicit a CD4<jats:sup>+<\/jats:sup> Th1-dominant immune response, but the mechanism regulating this process remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>NK cells were depleted and NKG2D was blocked with monoclonal antibodies in vivo. MDSCs, NK cells and T cells were assessed by flow cytometry and isolated by magnetic-activated cell sorting (MACS). MDSCs and NK cells were cocultured with T cells to determine their immunological function. The transcriptional profiles of MDSCs were measured by qRT-PCR and RNA-sequencing. Isolated NK cells and MDSCs by MACS were cocultured to study the viability and maturation of MDSCs regulated by NK cells. TIMER was used to comprehensively examine the immunological, clinical, and genomic features of tumors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>NK-cell activation after cryo-thermal therapy decreased MDSC accumulation and reprogrammed immunosuppressive MDSCs toward a mature phenotype to promote T cell antitumor immunity. Furthermore, we discovered that NK cells could kill MDSCs via the NKG2D-NKG2DL axis and promote MDSC maturation by interferon gamma (IFN-\u03b3) in response to NKG2D. In addition, CD4<jats:sup>+<\/jats:sup> Th1-dominant antitumor immune response was dependent on NKG2D, which promoted the major histocompatibility complex \u2161 pathway of MDSCs. High activated NK-cell infiltration and NKG2D level in tumors were positively correlated with better clinical outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Cryo-thermal therapy induces effective CD4<jats:sup>+<\/jats:sup> Th1-dominant antitumor immunity by activating NK cells to reprogram MDSCs, providing a promising therapeutic strategy for cancer immunotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2022-005769","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:49:47Z","timestamp":1671097787000},"page":"e005769","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-\u03b3 to modulate antitumor T-cell response after cryo-thermal therapy"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8341-3008","authenticated-orcid":false,"given":"Peng","family":"Peng","sequence":"first","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lou","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelu","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Du","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa X","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"2025100309003217000_10.12.e005769.1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2025100309003217000_10.12.e005769.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.011"},{"key":"2025100309003217000_10.12.e005769.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.01.004"},{"key":"2025100309003217000_10.12.e005769.4","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506"},{"key":"2025100309003217000_10.12.e005769.5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"2025100309003217000_10.12.e005769.6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1690"},{"key":"2025100309003217000_10.12.e005769.7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2025100309003217000_10.12.e005769.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0272-z"},{"key":"2025100309003217000_10.12.e005769.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0052-1"},{"key":"2025100309003217000_10.12.e005769.10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00235"},{"key":"2025100309003217000_10.12.e005769.11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01869"},{"key":"2025100309003217000_10.12.e005769.12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0655"},{"key":"2025100309003217000_10.12.e005769.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198687"},{"key":"2025100309003217000_10.12.e005769.14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00159"},{"key":"2025100309003217000_10.12.e005769.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007654108"},{"key":"2025100309003217000_10.12.e005769.16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.10.6711"},{"key":"2025100309003217000_10.12.e005769.17","doi-asserted-by":"crossref","DOI":"10.1038\/srep27136","article-title":"Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci Rep"},{"key":"2025100309003217000_10.12.e005769.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1459-7","article-title":"Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity","volume":"10","author":"He","year":"2019","journal-title":"Cell Death Dis"},{"key":"2025100309003217000_10.12.e005769.19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944115","article-title":"Th1-dominant CD4+ T cells orchestrate endogenous systematic antitumor immune memory after cryo-thermal therapy","volume":"13","author":"Peng","year":"2022","journal-title":"Front Immunol"},{"key":"2025100309003217000_10.12.e005769.20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/02656736.2019.1579373","article-title":"Cryo-thermal therapy inducing MI macrophage polarization created CXCL10 and IL-6-rich pro-inflammatory environment for CD4+ T cell-mediated anti-tumor immunity","volume":"36","author":"Liu","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"2025100309003217000_10.12.e005769.21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02656736.2017.1332394","article-title":"The cryo-thermal therapy-induced IL-6-rich acute pro-inflammatory response promoted DCs phenotypic maturation as the prerequisite to CD4+ T cell differentiation","volume":"34","author":"Liu","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"2025100309003217000_10.12.e005769.22","article-title":"Iron released after cryo-thermal therapy induced M1 macrophage polarization, promoting the differentiation of CD4+ T Cells into CTLs","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025100309003217000_10.12.e005769.23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000421"},{"key":"2025100309003217000_10.12.e005769.24","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.125","article-title":"The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response","volume":"8","author":"He","year":"2017","journal-title":"Cell Death Dis"},{"key":"2025100309003217000_10.12.e005769.25","first-page":"2064","article-title":"Role of NKG2D and its ligands in cancer immunotherapy","volume":"9","author":"Liu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"2025100309003217000_10.12.e005769.26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407"},{"key":"2025100309003217000_10.12.e005769.27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/02656736.2020.1788173","article-title":"Tumor-related HSP70 released after cryo-thermal therapy targeted innate immune initiation in the antitumor immune response","volume":"37","author":"Zhu","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"2025100309003217000_10.12.e005769.28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front Immunol"},{"key":"2025100309003217000_10.12.e005769.29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.7.1019"},{"key":"2025100309003217000_10.12.e005769.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.4128"},{"key":"2025100309003217000_10.12.e005769.31","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1111\/ajt.15497","article-title":"SIRP\u03b1\/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells","volume":"19","author":"Pengam","year":"2019","journal-title":"Am J Transplant"},{"key":"2025100309003217000_10.12.e005769.32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633205","article-title":"Natural killer cell interactions with myeloid derived suppressor cells in the tumor microenvironment and implications for cancer immunotherapy","volume":"12","author":"Zalfa","year":"2021","journal-title":"Front Immunol"},{"key":"2025100309003217000_10.12.e005769.33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000355126","article-title":"Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models","volume":"6","author":"Shime","year":"2014","journal-title":"J Innate Immun"},{"key":"2025100309003217000_10.12.e005769.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143776"},{"key":"2025100309003217000_10.12.e005769.35","doi-asserted-by":"crossref","first-page":"12621","DOI":"10.18632\/oncotarget.2181","article-title":"Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells","volume":"5","author":"Sun","year":"2014","journal-title":"Oncotarget"},{"key":"2025100309003217000_10.12.e005769.36","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0572"},{"key":"2025100309003217000_10.12.e005769.37","doi-asserted-by":"crossref","first-page":"b18","DOI":"10.1093\/immadv\/ltab018","article-title":"A summary of current NKG2D-based CAR clinical trials","volume":"1","author":"Curio","year":"2021","journal-title":"Immunother Adv"},{"key":"2025100309003217000_10.12.e005769.38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41586-022-04772-4","article-title":"A vaccine targeting resistant tumours by dual T cell plus NK cell attack","volume":"606","author":"Badrinath","year":"2022","journal-title":"Nature"},{"key":"2025100309003217000_10.12.e005769.39","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.272"},{"key":"2025100309003217000_10.12.e005769.40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00827"},{"key":"2025100309003217000_10.12.e005769.41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20010934"},{"key":"2025100309003217000_10.12.e005769.42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-052977"},{"key":"2025100309003217000_10.12.e005769.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2010.02435.x"},{"key":"2025100309003217000_10.12.e005769.44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32919","article-title":"Tumor-derived CSF-1 induces the NKG2D ligand RAE-1\u03b4 on tumor-infiltrating macrophages","volume":"7","author":"Thompson","year":"2018","journal-title":"Elife"},{"key":"2025100309003217000_10.12.e005769.45","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd4344","article-title":"A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity","volume":"6","author":"Boulch","year":"2021","journal-title":"Sci Immunol"},{"key":"2025100309003217000_10.12.e005769.46","doi-asserted-by":"crossref","first-page":"151r","DOI":"10.1126\/scitranslmed.3010162","article-title":"Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity","volume":"6","author":"Adusumilli","year":"2014","journal-title":"Sci Transl Med"},{"key":"2025100309003217000_10.12.e005769.47","doi-asserted-by":"crossref","unstructured":"Wang D , Aguilar B , Starr R , et al . Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity. JCI Insight 2018;3.doi:10.1172\/jci.insight.99048","DOI":"10.1172\/jci.insight.99048"},{"key":"2025100309003217000_10.12.e005769.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04390-6"},{"key":"2025100309003217000_10.12.e005769.49","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0044-0"},{"key":"2025100309003217000_10.12.e005769.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.11.001"},{"key":"2025100309003217000_10.12.e005769.51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01466","article-title":"Chronic NKG2D engagement in vivo differentially impacts NK cell responsiveness by activating NK receptors","volume":"8","author":"Koch","year":"2017","journal-title":"Front Immunol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2022-005769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:00:43Z","timestamp":1759507243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2022-005769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,15]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/jitc-2022-005769"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2022-005769","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}